NO961429L - Fremgangsmåte for fremstilling av kinolonholdige, orale preparater - Google Patents

Fremgangsmåte for fremstilling av kinolonholdige, orale preparater

Info

Publication number
NO961429L
NO961429L NO961429A NO961429A NO961429L NO 961429 L NO961429 L NO 961429L NO 961429 A NO961429 A NO 961429A NO 961429 A NO961429 A NO 961429A NO 961429 L NO961429 L NO 961429L
Authority
NO
Norway
Prior art keywords
quinolone
preparation
oral preparations
containing oral
introducing
Prior art date
Application number
NO961429A
Other languages
English (en)
Other versions
NO961429D0 (no
Inventor
Gabriel Gousset
Philippe Riviere
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of NO961429D0 publication Critical patent/NO961429D0/no
Publication of NO961429L publication Critical patent/NO961429L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En forbedret, oral formulering av aktive bestanddeler fra kinolonklassen oppnås ved en fremgangsmåte som omfatter innføring av et kompakteringstrinn med efterfølgende oppmaling før den egentlige kompresjon av blandingen av aktiv bestanddel og drøyemidler.
NO961429A 1993-10-21 1996-04-11 Fremgangsmåte for fremstilling av kinolonholdige, orale preparater NO961429L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.
PCT/FR1994/001212 WO1995011023A1 (fr) 1993-10-21 1994-10-19 Procede de preparation de compositions orales contenant des quinolones

Publications (2)

Publication Number Publication Date
NO961429D0 NO961429D0 (no) 1996-04-11
NO961429L true NO961429L (no) 1996-04-11

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961429A NO961429L (no) 1993-10-21 1996-04-11 Fremgangsmåte for fremstilling av kinolonholdige, orale preparater

Country Status (30)

Country Link
US (1) US5840333A (no)
EP (1) EP0724442A1 (no)
AT (1) ATA905894A (no)
AU (1) AU7997094A (no)
BE (1) BE1007326A3 (no)
CA (1) CA2174444A1 (no)
CH (1) CH686555A5 (no)
CO (1) CO4180603A1 (no)
CZ (1) CZ113696A3 (no)
DZ (1) DZ1818A1 (no)
EE (1) EE9600050A (no)
ES (1) ES2126474B1 (no)
FI (1) FI961717A7 (no)
FR (1) FR2711524B1 (no)
GB (1) GB2297908B (no)
GR (1) GR1002181B (no)
HU (1) HUT74181A (no)
IE (1) IE940838A1 (no)
IT (1) IT1270672B (no)
LU (1) LU88724A1 (no)
MA (1) MA23331A1 (no)
NO (1) NO961429L (no)
NZ (1) NZ274874A (no)
OA (1) OA10282A (no)
PL (1) PL314005A1 (no)
SG (1) SG52202A1 (no)
SK (1) SK50596A3 (no)
TN (1) TNSN94110A1 (no)
WO (2) WO1995011022A1 (no)
ZA (1) ZA948175B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186245B (no) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DK1083885T3 (da) * 1998-06-11 2007-02-26 Pharmacia & Upjohn Co Llc Delavirdintabletformulering
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
KR101289115B1 (ko) * 2004-08-13 2013-07-23 엠에스디 인터내셔널 홀딩즈 게엠베하 항생제인 트리아졸 및 코르티코스테로이드를 포함하는약제학적 제형

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
SK50596A3 (en) 1997-02-05
GR1002181B (en) 1996-03-12
ATA905894A (de) 2000-06-15
US5840333A (en) 1998-11-24
OA10282A (fr) 1997-10-07
FR2711524A1 (fr) 1995-05-05
DZ1818A1 (fr) 2002-02-17
EP0724442A1 (fr) 1996-08-07
CH686555A5 (fr) 1996-04-30
AU7997094A (en) 1995-05-08
CZ113696A3 (en) 1996-07-17
ES2126474B1 (es) 1999-11-16
FI961717A0 (fi) 1996-04-19
ZA948175B (en) 1995-06-08
NZ274874A (en) 1997-10-24
TNSN94110A1 (fr) 1995-09-21
PL314005A1 (en) 1996-08-05
ITMI942130A1 (it) 1996-04-19
GB9608316D0 (en) 1996-06-26
ES2126474A1 (es) 1999-03-16
IT1270672B (it) 1997-05-07
FR2711524B1 (fr) 1995-11-24
EE9600050A (et) 1996-10-15
CA2174444A1 (fr) 1995-04-27
GB2297908A (en) 1996-08-21
GB2297908B (en) 1997-12-10
BE1007326A3 (fr) 1995-05-16
WO1995011023A1 (fr) 1995-04-27
FI961717L (fi) 1996-04-19
MA23331A1 (fr) 1995-04-01
HUT74181A (en) 1996-11-28
WO1995011022A1 (fr) 1995-04-27
LU88724A1 (fr) 1996-08-23
NO961429D0 (no) 1996-04-11
CO4180603A1 (es) 1995-06-07
SG52202A1 (en) 1998-09-28
HU9601041D0 (en) 1996-06-28
IE940838A1 (en) 1995-05-03
ITMI942130A0 (it) 1994-10-19
FI961717A7 (fi) 1996-04-19

Similar Documents

Publication Publication Date Title
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
TR199802698T2 (xx) Valsartan�n kat� oral doz formlar�.
FR2771291B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
NO843563L (no) Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
EE03551B1 (et) Tahke oraalne preparaat, mis sisaldab toimeainena olansapiini, selle valmistamismeetod ja kasutamine
TW221056B (no)
NO982414L (no) Ny kombinasjon
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
SE8505736L (sv) Beredningar, huvudsakligen konfektberedningar, som reducerar tandkariesfrekvensen samt forfarande for framstellning av dessa beredningar
FR2771292B1 (fr) Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
SI1274685T1 (sl) Derivat piridin-1-oksida in postopek njegove transformacije v farmacevtsko ucinkovite sestavine
AU583166B2 (en) Oral garlic preparations and process for preparing same
NO961429L (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
AU586410B2 (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
WO2003045326A3 (en) Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
IE870577L (en) Topical amide preparation
DK0751940T3 (da) Sesquiterpenderivater
NO990283L (no) Formulering for behandling og/eller profylakse av demens
NO972605L (no) Ny fremgangsmåte for fremstilling av ranitidin
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь
AU2798884A (en) 2-alkylthio-1-aminoalkyl-2-pyroline-3-carbonitriles
IT8120177A0 (it) Derivato della l-prolina, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.